Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
Subscribe To Our Newsletter & Stay Updated
